Smith & Nephew's Advanced Wound Management division has released results from 11 studies of products and therapies from its Allevyn, Acticoat, Iodosorb and Renasys wound care portfolio.
The multicenter, non-comparative, prospective study of Iodosorb is designed to evaluate the effect of Iodosorb on bioburden load and other wound characteristics in diabetic foot ulcers.
The company also released data from the new Allevyn Gentle Border Multisite dressing which features imaginative shape to fit the contours of the body, and stay in place.
St Lukes-Roosevelt Hospital Center Department of Surgery Clinical Research director and Endovascular-Vascular Surgery division chief John Lantis said the study results showed that when Iodosorb was used on diabetic foot ulcers, significant reductions in wound area, levels of exudates and pain were seen in patients, as well as an improvement in wound appearance.
Smith & Nephew North American Advanced Wound Management Division president Thomas Dugan said imaginative solutions like their new Human Shaped Allevyn dressings help improve outcomes for patients and at the same time conserve resources for health care systems.